The facility, which will support six to eight biotech startups, is set to open next year. Julie Gilmore, Vice President and Global Head of Lilly Gateway Labs, said that Eli Lilly was attracted to Philadelphia due to its longstanding breakthroughs in biotech innovation, including gene therapy and CAR T-cell therapy. Learn more here.